NCT06334965View on ClinicalTrials.gov

Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort

NARecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

November 30, 2027

Study Completion Date

September 30, 2029

Conditions
Hepatocellular CarcinomaRadioembolization
Interventions
OTHER

Simultaneous 18F-Choline PET-MRI

before first TARE administration (after work-up procedure) and one month after TARE administration

Trial Locations (5)

75018

ACTIVE_NOT_RECRUITING

Service de medecine nucleaire, Hôpital Bichat, Paris

92110

RECRUITING

Service de Médecine Nucléaire, Hôpital Beaujon, Clichy

Unknown

RECRUITING

Beaujon hospital, Clichy

ACTIVE_NOT_RECRUITING

CHU Nantes, Nantes

RECRUITING

Service de Médecine Nucléaire, CHU de Nantes, Nantes

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER